Men's Health News

RSS

UH conducts first ever pilot study to test heat therapy for treatment of PE

University Hospitals Case Medical Center is conducting the first ever pilot study to test a new procedure using "heat therapy" or local radiofrequency energy to treat premature ejaculation.

9 Mar 2011

Jobless African-American men may face risk of depression

Jobless African-American men might be at a greater risk of suffering from depression, new research shows. More surprising, at the other end of the income spectrum, African-American men making $80,000 and upward are also among those at higher risk.

9 Mar 2011

5a-reductase inhibitors for male health problems can affect sexual health

A new study published in The Journal of Sexual Medicine reveals that, for the first time, 5a-reductase inhibitors commonly used to treat urinary problems in patients with benign prostatic hyperplasia (BPH) and found in popular medications to treat hair loss, can produce, persistent erectile dysfunction (ED), depression and loss of libido, even after the medication has been discontinued.

7 Mar 2011

Research findings likely to improve understanding of gene regulation in humans

Many multi-cellular animals use sex chromosomes to determine sex. In fruit flies and in humans, this produces XX for females and XY for males. Cellular mechanisms then kick into gear to compensate the two-to-one imbalance of X-linked genes in females and males.

4 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

New study: Significant deterioration in semen quality during last 10 years in Finland

A new study published in the International Journal of Andrology reveals that semen quality has significantly deteriorated during the last ten years in Finland, a country that previously was a region with high sperm counts.

3 Mar 2011

Study: Men who consume non-steroidals more likely to have erectile dysfunction

Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.

3 Mar 2011

Tenofovir gel may help reduce risk of HIV from anal sex

A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel could help reduce the risk of HIV from anal sex, even though the vaginal gel formulation may not be optimal for rectal use.

28 Feb 2011

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

As a world leader in the advancement of the detection and treatment of prostate cancer, the Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center is the first medical facility in the Northeast to install ei-Nav|Artemis™, an innovative image guidance and navigation system for prostate biopsy that is manufactured by Eigen.

25 Feb 2011

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Amgen today announced the publication of results from a Phase 3 head-to-head trial that compared XGEVA to Zometa in preventing bone complications called skeletal-related events in 1,901 men with prostate cancer and bone metastases.

25 Feb 2011

Variation in PSA levels does not predict prostate cancer, may lead to unnecessary biopsies

Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time — known as PSA velocity — is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.

25 Feb 2011

Focused Ultrasound Surgery Foundation releases men's heath update on prostate cancer, BPH treatments

The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter.

23 Feb 2011

Study: Cannabis use may negatively impact male sexual performance

Rany Shamloul's recent review of the medical literature on cannabis use and sexual health has revealed that cannabis use may negatively impact male sexual performance.

23 Feb 2011

CDC maps least and most active Americans

A new government commissioned study has found that Colorado has one of the most active populations in the country and Kentucky has one of the least active. This study is the third in a series of county-focused reports by the federal Centers for Disease Control and Prevention (CDC). The first two looked at diabetes and obesity rates, says Ann Albright, director of the CDC’s Division of Diabetes Translation.

20 Feb 2011

Jenny Craig to launch new male-targeted weight loss initiative

Jenny Craig, Inc., one of the leading authorities on weight management, is launching a new male-targeted initiative titled "Jen Works for Men" with celebrity spokesperson Jason Alexander as the face of the new campaign. Alexander, who famously lost 30 pounds on the program, wrote, directed and starred in the new series of national commercials for the weight loss company, slated to launch on Monday, February 21, 2011.

19 Feb 2011

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the 2011 Genitourinary Cancers Symposium held in Orlando, Florida on February 17 – 19, 2011.

19 Feb 2011

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.

18 Feb 2011

Skeleton regulates fertility in males, but not females

Researchers at Columbia University Medical Center have discovered that the skeleton acts as a regulator of fertility in male mice through a hormone released by bone, known as osteocalcin.

17 Feb 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health, Inc. today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient.

17 Feb 2011

Early balding linked to prostate cancer: Study

Balding early in life causes grief for many men and now new research will cause even more alarm. Researchers have found that early balding may be liked to prostate cancer.

16 Feb 2011

Men's Health News

UH conducts first ever pilot study to test heat therapy for treatment of PE

Jobless African-American men may face risk of depression

5a-reductase inhibitors for male health problems can affect sexual health

Research findings likely to improve understanding of gene regulation in humans

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

New study: Significant deterioration in semen quality during last 10 years in Finland

Study: Men who consume non-steroidals more likely to have erectile dysfunction

Tenofovir gel may help reduce risk of HIV from anal sex

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Variation in PSA levels does not predict prostate cancer, may lead to unnecessary biopsies

Focused Ultrasound Surgery Foundation releases men's heath update on prostate cancer, BPH treatments

Study: Cannabis use may negatively impact male sexual performance

CDC maps least and most active Americans

Jenny Craig to launch new male-targeted weight loss initiative

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Skeleton regulates fertility in males, but not females

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Early balding linked to prostate cancer: Study

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News